Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.995
-0.025 (-1.24%)
At close: Jul 10, 2025, 4:00 PM
2.000
0.00 (0.00%)
Pre-market: Jul 11, 2025, 8:00 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Protein Kinase Inhibitor Therapeutics
260.50K
Log In
Log In
Log In
Log In
Upgrade
Protein Kinase Inhibitor Therapeutics Growth
111.03%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
United States
260.50K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
111.03%
Log In
Log In
Log In
Log In
Upgrade